FIBROSCINT Trademark

Trademark Overview

On Monday, August 17, 2020, a trademark application was filed for FIBROSCINT with the United States Patent and Trademark Office. The USPTO has given the FIBROSCINT trademark a serial number of 90118649. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, September 22, 2023. This trademark is owned by Capella Imaging, Inc.. The FIBROSCINT trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic imaging agent for cardiac imaging and the detection of blood clots
fibroscint

General Information

Serial Number90118649
Word MarkFIBROSCINT
Filing DateMonday, August 17, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, September 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2021

Trademark Statements

Goods and ServicesDiagnostic imaging agent for cardiac imaging and the detection of blood clots

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCapella Imaging, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 631464222
Party NameCapella Imaging, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 631464222

Trademark Events

Event DateEvent Description
Saturday, September 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023SOU EXTENSION 5 GRANTED
Monday, September 18, 2023SOU EXTENSION 5 FILED
Friday, September 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 14, 2023SOU EXTENSION 4 FILED
Tuesday, March 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2022SOU EXTENSION 3 GRANTED
Friday, September 16, 2022SOU EXTENSION 3 FILED
Friday, September 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2022SOU EXTENSION 2 GRANTED
Wednesday, March 16, 2022SOU EXTENSION 2 FILED
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Saturday, September 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 16, 2021SOU EXTENSION 1 GRANTED
Thursday, September 16, 2021SOU EXTENSION 1 FILED
Thursday, September 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 11, 2020ASSIGNED TO EXAMINER
Friday, September 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 20, 2020NEW APPLICATION ENTERED

Related Keywords

fibroscint imaging blood clots detection cardiac agent diagnostic